Facebook
Twitter
Telegram
Report an ErrorBOQI International Medical Balance Sheet 2011-2024 | BIMI
Annual Balance Sheet BOQI International Medical
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-1.49 M | -3.63 M | 609 K | 71 K | 5.8 M | 6.94 M | 5.64 M | 7.62 M | 8.65 M | 7.35 M | 6.67 M | 7.44 M |
Long Term Debt |
315 K | 538 K | 721 K | - | - | - | - | - | - | - | - | 960 K |
Long Term Debt Current |
533 K | 443 K | 23.1 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 743 K | - | - | - | - | - | - | - | - | 960 K |
Total Current Liabilities |
25.4 M | 22.1 M | 15.6 M | 21.5 M | 13.1 M | 14.1 M | 10.6 M | 14 M | 17 M | 10.8 M | 13 M | 13.3 M |
Total Liabilities |
30.5 M | 26.8 M | 16.3 M | 21.5 M | 13.1 M | 14.1 M | 10.6 M | 14 M | 17 M | 10.8 M | 13 M | 14.3 M |
Deferred Revenue |
- | - | - | 68 K | 357 K | 513 K | 487 K | 178 K | - | - | - | - |
Retained Earnings |
-70.1 M | -47.9 M | - | -10.9 M | -6.44 M | 10.3 M | 11.9 M | 13.7 M | 14.7 M | 17.5 M | 17.7 M | 17.6 M |
Total Assets |
35.7 M | 38.1 M | 33.2 M | 30.1 M | 23.1 M | 41.4 M | 37.3 M | 44.4 M | 48.3 M | 42.7 M | 42.8 M | 43.8 M |
Cash and Cash Equivalents |
2.34 M | 4.61 M | 135 K | 36.4 K | 17.9 K | 282 K | 125 K | 435 K | 1.3 M | 1.02 M | 3.07 M | 2.32 M |
Book Value |
5.22 M | 11.3 M | 16.9 M | 8.51 M | 9.99 M | 27.3 M | 26.7 M | 30.4 M | 31.3 M | 31.9 M | 29.8 M | 29.5 M |
Total Shareholders Equity |
4.05 M | 11.2 M | 16.7 M | 8.68 M | 10.1 M | 27.2 M | 26.7 M | 30.4 M | 31.3 M | 31.9 M | 29.8 M | 29.5 M |
All numbers in USD currency
Quarterly Balance Sheet BOQI International Medical
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
24.4 K | 126 K | 160 K | 315 K | 475 K | 472 K | 529 K | 538 K | 795 K | 924 K | 426 K | 721 K | 721 K | 721 K | 721 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
4.74 M | 4.76 M | 5.05 M | 5.13 M | 3.89 M | 4.31 M | 4.62 M | 4.7 M | - | - | 1.82 M | 743 K | - | - | 743 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
24.9 M | 24.1 M | 27.7 M | 28.9 M | 22.8 M | 25.8 M | 25.3 M | 26.8 M | 28.3 M | 32 M | 25.3 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 14 M | 14 M | 14 M | 14 M | 17 M | 17 M | 17 M | 17 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 13 M | 13 M | 13 M | 13 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 656 K | - | - | 513 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-71.4 M | -68.3 M | -71 M | -70.1 M | - | - | 50.6 M | 47.9 M | 18.2 M | 16.5 M | 16.2 M | 12.9 M | 10.8 M | 8.4 M | 13 M | 10.9 M | 8.42 M | 7.87 M | 7.01 M | 6.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
35 M | 36.7 M | 36.3 M | 34.1 M | 33 M | 40.2 M | 38.7 M | 38.1 M | 63.1 M | 62.6 M | 49.7 M | 33.2 M | 33.2 M | 33.2 M | 33.2 M | 30.1 M | 30.1 M | 30.1 M | 30.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 41.4 M | 41.4 M | 41.4 M | 41.4 M | 37.3 M | 37.3 M | 37.3 M | 37.3 M | 44.4 M | 44.4 M | 44.4 M | 44.4 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M | 42.7 M | 42.7 M | 42.7 M | 42.7 M | 42.8 M | 42.8 M | 42.8 M | 42.8 M | 43.8 M | 43.8 M | 43.8 M | 43.8 M |
Cash and Cash Equivalents |
994 K | 1.93 M | 1.73 M | 2.34 M | 1.05 M | 5.03 M | 1.61 M | 4.8 M | 210 K | 627 K | 2.83 M | 135 K | 135 K | 135 K | 135 K | 1.6 K | 36.4 K | 36.4 K | 36.4 K | 17.9 K | 202 K | 17.9 K | 17.9 K | 282 K | 282 K | 282 K | 282 K | 125 K | 125 K | 125 K | 125 K | 435 K | 435 K | 435 K | 435 K | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.02 M | 1.02 M | 1.02 M | 1.02 M | 3.07 M | 3.07 M | 3.07 M | 3.07 M | 2.32 M | 2.32 M | 2.32 M | 2.32 M |
Book Value |
10.1 M | 12.5 M | 8.62 M | 5.22 M | 10.2 M | 14.4 M | 13.4 M | 11.3 M | 34.8 M | 30.6 M | 24.5 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 8.51 M | 8.51 M | 8.51 M | 8.51 M | 9.99 M | 9.99 M | 9.99 M | 9.99 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 26.7 M | 26.7 M | 26.7 M | 26.7 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 31.9 M | 31.9 M | 31.9 M | 31.9 M | 29.8 M | 29.8 M | 29.8 M | 29.8 M | 29.5 M | 29.5 M | 29.5 M | 29.5 M |
Total Shareholders Equity |
8.71 M | 10.9 M | 7.61 M | 4.05 M | 9.8 M | 14.2 M | 13.3 M | 11.2 M | 34.5 M | 30.4 M | 24.3 M | 16.7 M | 16.7 M | 16.7 M | 16.7 M | 8.68 M | 8.68 M | 8.68 M | 8.68 M | 9.99 M | 10.1 M | 10.1 M | 10.1 M | 27.3 M | 27.2 M | 27.2 M | 27.2 M | 26.7 M | 26.7 M | 26.7 M | 26.7 M | 30.4 M | 30.4 M | 30.4 M | 30.4 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 31.9 M | 31.9 M | 31.9 M | 31.9 M | 29.8 M | 29.8 M | 29.8 M | 29.8 M | 29.5 M | 29.5 M | 29.5 M | 29.5 M |
All numbers in USD currency